Blog

“This initiative is geared towards identifying additional biomarkers that can aid in selecting the most appropriate treatments for ovarian cancer.” Credit: 2023 Ray et al. “This initiative is geared towards identifying additional biomarkers that can aid in selecting the most appropriate treatments for ovarian cancer.”

A research group led by Prof. WANG Hui from the Hefei Institutes of Physical Science (HFIPS) of the Chinese Academy of Sciences has introduced a metal-free nanozyme based on graphene quantum dots (GQDs) for highly efficient tumor chemodynamic therapy (CDT). Credit: FHIPS A research group

CHAPEL HILL, N.C. – Every time a cancer cell divides, it sustains damage to its own DNA molecules. Researchers, including Gaorav Gupta, MD, PhD, associate professor in the Department of Radiation Oncology at the UNC School of Medicine, have long wondered how cancers are able

Boston – Like a criminal entering a witness protection program, cancer cells can shed their past and take on a new identity. Detecting such an identity-switch is particularly challenging when metastatic castration-resistant prostate cancer (CRPC) advances from adenocarcinoma to neuroendocrine prostate cancer (NEPC), a very

LOS ANGELES — Physicians at City of Hope, one of the largest cancer research and treatment organizations in the United States, in cooperation with the Children’s Oncology Group (COG), have conducted the largest clinical trial to date seeking to reduce the risk of people who

  Credit: Photo by Sylvester   MIAMI, FLORIDA (EMBARGOED UNTIL JAN. 9, 2024 AT 4 PM EST) – A multicenter collaboration led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has produced the first computational model for

Researchers at the Montreal Behavioural Medicine Centre (MBMC) say people with noncommunicable diseases (NCDs) such as heart disease, cancer, diabetes, or chronic lung ailments were disproportionately impacted by the COVID-19 pandemic. Credit: Concordia University Researchers at the Montreal Behavioural Medicine Centre (MBMC) say people with noncommunicable diseases (NCDs) such

The University of Rochester will house a new national center focused on using tissue-on-chip technology to develop drugs more rapidly and reduce the need for animal trials. The National Institutes of Health awarded a $7.5 million grant to establish the Translational Center for Barrier Microphysiological Systems (TraCe-bMPS) at Rochester

In her latest study, Kim Kaphingst, ScD, director of cancer communication research at Huntsman Cancer Institute and professor of communications at the University of Utah, is using chatbots to reach Spanish-speaking patients and teach them about genetic testing.  Credit: Huntsman Cancer Institute In her latest

Researchers from Tokyo Medical and Dental University (TMDU) use various technologies to better characterize a rare form of leukemia on the molecular level Credit: Department of Pediatrics and Developmental Biology, TMDU Researchers from Tokyo Medical and Dental University (TMDU) use various technologies to better characterize